Search by Drug Name or NDC
NDC 43066-0090-25 PROCHLORPERAZINE EDISYLATE 5 mg/mL Details
PROCHLORPERAZINE EDISYLATE 5 mg/mL
PROCHLORPERAZINE EDISYLATE is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is PROCHLORPERAZINE EDISYLATE.
Product Information
| NDC | 43066-0090 |
|---|---|
| Product ID | 43066-090_e913c559-48fc-42e7-b8d0-de083005171f |
| Associated GPIs | 59200055202010 |
| GCN Sequence Number | 067700 |
| GCN Sequence Number Description | prochlorperazine edisylate VIAL 10 MG/2 ML INJECTION |
| HIC3 | H6J |
| HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
| GCN | 30314 |
| HICL Sequence Number | 001628 |
| HICL Sequence Number Description | PROCHLORPERAZINE EDISYLATE |
| Brand/Generic | Generic |
| Proprietary Name | PROCHLORPERAZINE EDISYLATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | prochlorperazine edisylate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/mL |
| Substance Name | PROCHLORPERAZINE EDISYLATE |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Phenothiazine [EPC], Phenothiazines [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA214379 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43066-0090-25 (43066009025)
| NDC Package Code | 43066-090-25 |
|---|---|
| Billing NDC | 43066009025 |
| Package | 25 VIAL in 1 CARTON (43066-090-25) / 2 mL in 1 VIAL (43066-090-01) |
| Marketing Start Date | 2021-05-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |